An N-terminal CDC42 T43I variant reveals the mechanism of pyrin inflammasome activation.

A heterozygous CDC42 T43I variant enhances pyrin inflammasome activation, revealing a new regulatory mechanism in autoinflammatory responses.

• Why it matters: Understanding how CDC42 influences inflammasome activation addresses gaps in knowledge about autoinflammatory diseases like familial Mediterranean fever and could inform targeted therapies.
• What they did: Researchers identified the T43I mutation in CDC42 and used molecular interaction studies to show it strengthens CDC42-pyrin binding, increasing inflammasome activity and cytokine production.
• The result: This discovery positions CDC42 as a pyrin ligand, highlighting a dual regulatory pathway involving RHOA and CDC42, which may lead to novel interventions for autoinflammatory conditions.